A. Cristina de Melo

519MO Phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial of cemiplimab in recurrent or metastatic (R/M) cervical cancer: Long-term survival analysis

B. Monk, Shin-ichiro Takahashi, V. Samouëlian, 2022, Annals of Oncology.